Published in AIDS Weekly, May 12th, 1997
BCX-34 is a small-molecule drug that modulates the proliferation of T cells. Based on preclinical studies, scientists at the University of Alabama at Birmingham (UAB) and BioCryst theorize that BCX-34 may reduce HIV load in the bloodstream by inhibiting the replication of infected T cells.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.